Neuropeptide FF and related peptides attenuates warm-, but not cold-water swim stress-induced analgesia in mice

Behavioural Brain Research

Volumn 233, Issue 2, 2012, Pages 428-433

  Li, Ning ^a   Han, Zheng Lan ^a   Fang, Quan ^a   Wang, Zi Long ^a   Tang, Hong Zhu ^a   Ren, Hui ^a   Wang, Rui ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

Forced swimming; Mice; Neuropeptide FF (NPFF); Opioid modulating; Stress induced analgesia (SIA)

Indexed keywords

COLD WATER; DIZOCILPINE; HOT WATER; NALOXONE; NEUROPEPTIDE; NEUROPEPTIDE FF; NEUROPEPTIDE FF1 RECEPTOR; NEUROPEPTIDE FF2 RECEPTOR; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE VF; RECEPTOR BLOCKING AGENT; RF 9; UNCLASSIFIED DRUG; WATER;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; FORCED SWIMMING TEST; MALE; MOUSE; NEUROMODULATION; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ADAMANTANE; ANALGESIA; ANALYSIS OF VARIANCE; ANIMALS; COLD TEMPERATURE; DIPEPTIDES; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; HOT TEMPERATURE; INJECTIONS, INTRA-ARTICULAR; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED STRAINS; NALOXONE; NARCOTIC ANTAGONISTS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; OLIGOPEPTIDES; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 84862321657     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.05.035     Document Type: Article

References (36)

1. Yang H.Y., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proceedings of the National Academy of Sciences of the United States of America 1985, 82:7757-7761.
2. Perry S.J., Yi-Kung Huang E., Cronk D., Bagust J., Sharma R., Walker R.J., et al. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Letters 1997, 409:426-430.
3. Vilim F.S., Aarnisalo A.A., Nieminen M.L., Lintunen M., Karlstedt K., Kontinen V.K., et al. Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Molecular Pharmacology 1999, 55:804-811.
4. Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. Journal of Biological Chemistry 2000, 275:39324-39331.
5. Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. Journal of Biological Chemistry 2000, 275:25965-25971.
6. Hinuma S., Shintani Y., Fukusumi S., Iijima N., Matsumoto Y., Hosoya M., et al. New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nature Cell Biology 2000, 2:703-708.
7. Liu Q., Guan X.M., Martin W.J., McDonald T.P., Clements M.K., Jiang Q., et al. Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. Journal of Biological Chemistry 2001, 276:36961-36969.
8. Mollereau C., Mazarguil H., Marcus D., Quelven I., Kotani M., Lannoy V., et al. Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. European Journal of Pharmacology 2002, 451:245-256.
9. Roussin A., Serre F., Gouarderes C., Mazarguil H., Roumy M., Mollereau C., et al. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity. Biochemical and Biophysical Research Communications 2005, 336:197-203.
10. Gouarderes C., Mazarguil H., Mollereau C., Chartrel N., Leprince J., Vaudry H., et al. Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding. Neuropharmacology 2007, 52:376-386.
11. Yoshida H., Habata Y., Hosoya M., Kawamata Y., Kitada C., Hinuma S. Molecular properties of endogenous RFamide-related peptide-3 and its interaction with receptors. Biochimica et Biophysica Acta 2003, 1593:151-157.
12. Panula P., Aarnisalo A.A., Wasowicz K., Neuropeptide F.F. a mammalian neuropeptide with multiple functions. Progress in Neurobiology 1996, 48:461-487.
13. Roumy M., Zajac J.M. Neuropeptide FF, pain and analgesia. European Journal of Pharmacology 1998, 345:1-11.
14. Panula P., Kalso E., Nieminen M., Kontinen V.K., Brandt A., Pertovaara A. Neuropeptide FF and modulation of pain. Brain Research 1999, 848:191-196.
15. Gouarderes C., Quelven I., Mollereau C., Mazarguil H., Rice S.Q., Zajac J.M. Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands. Neuroscience 2002, 115:349-361.
16. Quelven I., Roussin A., Zajac J.M. Comparison of pharmacological activities of neuropeptide FF1 and neuropeptide FF2 receptor agonists. European Journal of Pharmacology 2005, 508:107-114.
17. Fang Q., Guo J., He F., Peng Y.L., Chang M., Wang R. In vivo inhibition of neuropeptide FF agonism by BIBP3226, an NPY Y1 receptor antagonist. Peptides 2006, 27:2207-2213.
18. Fang Q., Jiang T.N., Li N., Han Z.L., Wang R. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice. Protein and Peptide Letters 2011, 18:403-409.
19. Fang Q., Han Z.L., Li N., Wang Z.L., He N., Wang R. Effects of neuropeptide FF system on CB(1) and CB(2) receptors mediated antinociception in mice. Neuropharmacology 2012, 62:855-864.
20. Altier N., Stewart J. Neuropeptide FF in the VTA blocks the analgesic effects of both intra-VTA morphine and exposure to stress. Brain Research 1997, 758:250-254.
21. Kavaliers M., Innes D. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia. Peptides 1992, 13:603-607.
22. Mogil J.S., Sternberg W.F., Balian H., Liebeskind J.C., Sadowski B. Opioid and nonopioid swim stress-induced analgesia: a parametric analysis in mice. Physiology & Behavior 1996, 59:123-132.
23. Marek P., Mogil J.S., Sternberg W.F., Panocka I., Liebeskind J.C. N-methyl-D-aspartic acid (NMDA) receptor antagonist MK-801 blocks non-opioid stress-induced analgesia. II. Comparison across three swim-stress paradigms in selectively bred mice. Brain Research 1992, 578:197-203.
24. Galina Z.H., Kastin A.J. MIF-1 antagonizes warm-, but not cold-water stress-induced analgesia: dissociation from immobility. Peptides 1985, 6:1109-1112.
25. Butler R.K., Finn D.P. Stress-induced analgesia. Progress in Neurobiology 2009, 88:184-202.
26. Rizzi A., Marzola G., Bigoni R., Guerrini R., Salvadori S., Mogil J.S., et al. Endogenous nociceptin signaling and stress-induced analgesia. Neuroreport 2001, 12:3009-3013.
27. Mollereau C., Roumy M., Zajac J.M. Opioid-modulating peptides: mechanisms of action. Current Topics in Medicinal Chemistry 2005, 5:341-355.
28. Yang H.Y., Iadarola M.J. Modulatory roles of the NPFF system in pain mechanisms at the spinal level. Peptides 2006, 27:943-952.
29. Roumy M., Garnier M., Zajac J.M. Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones. Neuroscience Letters 2003, 348:159-162.
30. Simonin F., Schmitt M., Laulin J.P., Laboureyras E., Jhamandas J.H., MacTavish D., et al. RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:466-471.
31. Fang Q., Wang Y.Q., He F., Guo J., Guo J., Chen Q., et al. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist. Regulatory Peptides 2008, 147:45-51.
32. Mouledous L., Mollereau C., Zajac J.M. Opioid-modulating properties of the neuropeptide FF system. Biofactors 2010, 36:423-429.
33. Rebeyrolles S., Zajac J.M., Roumy M. Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones. Neuroreport 1996, 7:2979-2981.
34. Mollereau C., Mazarguil H., Zajac J.M., Roumy M., Neuropeptide F.F. (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Molecular Pharmacology 2005, 67:965-975.
35. Kersante F., Mollereau C., Zajac J.M., Roumy M. Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model. Peptides 2006, 27:980-989.
36. Xia Y.F., Arai A.C. Prolactin-releasing peptide enhances synaptic transmission in rat thalamus. Neuroscience 2011, 172:1-11.